Fig. 1: Alterations in inflammatory, hepatic, metabolic and infectious biomarkers in blood from patients with COVID-19 or H1N1 infections compared with HCs. | Communications Biology

Fig. 1: Alterations in inflammatory, hepatic, metabolic and infectious biomarkers in blood from patients with COVID-19 or H1N1 infections compared with HCs.

From: Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features

Fig. 1: Alterations in inflammatory, hepatic, metabolic and infectious biomarkers in blood from patients with COVID-19 or H1N1 infections compared with HCs.

Significantly altered (A) blood haemocytes and haemoglobin, B liver function indicators, C inflammatory cytokines, and (D) metabolic and infectious biomarkers in the blood of patients with COVID-19 (n = 67) or H1N1 (n = 35) infections compared with HCs (n = 48). *P < 0.05; **P < 0.01; and ***P < 0.001.

Back to article page